Luvo Medical Technologies

Luvo Medical Technologies, often referred to as LUVO, is a private company that develops and provides medical aesthetic technologies. The company's headquarters are located in Cambridge, Ontario, Canada. While a precise founding year is not explicitly stated, the company appears to have commenced operations around 2020-2021, coinciding with its initial FDA filings and product launches. LUVO does not disclose its employee count or revenue figures.

LUVO specializes in a range of medical aesthetic devices and solutions for physicians and medical professionals. Their product portfolio includes multi-modality workstations like DARWIN, cryo systems such as COOL FORM, and IPL systems like LUCENT IPL, which also addresses dry eye treatments. They also offer systems for skin health (BELA MD+), laser hair removal (BARE 808), and Platelet-Rich Plasma (WORLDPRP), utilizing technologies such as IPL, laser, radio frequency, microneedling, and HIFU. The company's products are designed to support treatments for acne, body contouring, skin rejuvenation, hair removal, and various other dermatological and aesthetic concerns.

In patent litigation, Luvo Medical Technologies maintains a defensive posture. The company has been named as a defendant in one tracked case and has no recorded appearances as a plaintiff. This indicates that LUVO operates as an operating company that defends against intellectual property challenges, rather than asserting patents as a non-practicing entity.

The sole tracked case involving Luvo Medical Technologies is HydraFacial LLC v. Luvo Medical Technologies, filed on August 16, 2024, in the U.S. District Court for the District of Utah. In a related development, Luvo Medical Technologies acquired Zimed PF, an ophthalmology product, from Aequus Pharmaceuticals in May 2025, further expanding its offerings in the medical field.